Rasagiline Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-D-0011
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Rasagiline Tablets, as detailed under procurement identifier SPE2D2-26-D-0011. This contract is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating its focus on pharmaceutical products.
The primary objective of this procurement is to ensure a reliable supply of Rasagiline Tablets, a pharmaceutical product commonly used in the treatment of Parkinson’s disease, to support the medical needs of the Department of Defense and its associated entities. The scope of the contract encompasses the manufacturing and delivery of these tablets to the designated place of performance in Delran, New Jersey, United States. The intended outcome is to maintain a consistent and high-quality supply chain for this critical medication, thereby supporting the health and readiness of military personnel and beneficiaries.
Key requirements for this contract include adherence to stringent pharmaceutical manufacturing standards as outlined by federal regulations, ensuring product quality, safety, and efficacy. The contractor is expected to deliver Rasagiline Tablets in accordance with the specifications and quantities determined by DLA Troop Support. All deliverables must comply with applicable regulatory guidelines and be suitable for use within the federal healthcare system.
The contracting entity for this award is DLA Troop Support, a federal office within the Defense Logistics Agency. The primary point of contact for this procurement is Kyle Lewicki, who can be reached at [email protected] or by phone at 445-737-0977. A secondary contact is Jason Wray, available at [email protected] or 445-737-6304. The place of performance for this contract is Delran, New Jersey.
This procurement is an award notice, indicating that the contract has already been awarded and is currently active as of February 4, 2026. The notice is accessible via the SAM.gov portal, with the opportunity ID f1e564492b28427eb14159391fd205c6. Contractors interested in similar future opportunities should note the classification codes and requirements, as these elements are likely to remain consistent across comparable pharmaceutical supply contracts managed by DLA Troop Support.
No specific set-aside requirements or special considerations are indicated in the notice. The focus remains on the consistent supply of pharmaceutical-grade Rasagiline Tablets, manufactured and delivered in compliance with federal standards, to support the ongoing needs of the Department of Defense.
For further details or to review the official award documentation, interested parties are encouraged to consult the notice on SAM.gov or contact the designated representatives.